Shandong Tumor Hospital
Alternate names 山东省肿瘤医院, Shandong Cancer Hospital
Related institution Shandong First Medical University
ROR: Yes
Works count: 7,049
Citations count: 90,610
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
2021 · Zhenggang Ren, Jianming Xu, et al. · The Lancet Oncology
PD-L1 expression in human cancers and its association with clinical outcomes
2016 · Jinming Yu, Xin Wang, et al. · OncoTargets and Therapy
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
2010 · Lei Kong, Junjie Zhu, et al. · Acta Diabetologica